-
Most Popular
Search Results
240 results for bmti
British American Tobacco (BTI) a Buy on Solid Quant Score
British American Tobacco Plc (NYSE:BTI) is a $66.3 billion in market value component of the Tobacco GICS industry group where currently BTI is ranked 1…
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy
At $65.63, Bristol-Myers Squibb Co (BMY) a Buy based on the latest stock market ratings, and comparative pricing of its shares.
Strong Quant Score Make Bristol-Myers Squibb Co (BMY) a Buy at recent price of $60.96
The a Buy rating for BMY is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and…
Rating for Bristol-Myers Squibb Co (BMY) Drops….. Wilting Earnings Visibility
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) is the result of using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates…
Bristol-Myers Squibb Co (BMY) Sees Downgrade….. Poor Earnings Momentum
Currently, Bristol-Myers Squibb Co (NYSE:BMY) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall…
Shares in Bristol-Myers Squibb Co (BMY) and Merck & Co., Inc. (MRK) Need to Chill
Friday’s action in pharma giants Merck (MRK) and Bristol-Myers Squibb (BMY) is likely overdone to the upside and down.
Bristol-Myers Squibb Co (BMY) Stock Raised to Hold
Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates…
3 Medical Devices Stocks to Sell Now
The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
Go Long Bristol-Myers Squibb Co (BMY) Stock for Panic Profits!
Pharmaceutical stocks like Bristol-Myers Squibb (BMY) have been toxic for months, but BMY stock is about to turn lemons into lemonade.
BMY Stock: Don’t Try to Catch This Falling Knife … Yet
Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline.
BMY Stock: It’s Time to Buy Bristol-Myers Squibb Co
Following a failed cancer drug approval, BMY stock dropped nearly 16%. That appears to be an overreaction, so time to take a bullish stance.
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb.
Bristol-Myers Squibb Co (BMY) Suffers Heavy Dose of Disappointment
BMY stock — at around $49 — is now fairly valued. But given its failure rate, waiting for Bristol-Myers to get to “cheap” is the…
BITI ETF Gains as Investors Look to Short Bitcoin Amid Crypto Crash
The ProShares Short Bitcoin Strategy ETF, or BITI, has gotten off to a strong start as investors bet against the biggest cryptocurrency.
Best Stocks 2022: Why Bristol-Myers Squibb (BMY) Stock Is a Clear Winner
There’s a reason BMY stock is currently winning our Best Stocks for 2022 contest. Investors should buy BMY for value, safety and dividends.
Bristol-Myers Squibb Has Great Potential Ahead of Earnings
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
Why EOG Resources Inc (EOG), Merck & Co., Inc. (MRK) and Rackspace Hosting, Inc. (RAX) Are 3 of Today’s Best Stocks
As stocks jumped following the jobs report, EOG, MRK and RAX were among Friday’s standouts.
Bristol-Myers Squibb Co: The BMY Freefall Is Overdone
BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support.
Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout
With its Celgene (CELG) buyout, Bristol-Meyers is getting a heck of a deal and will make BMY stock the top-dog cancer medicines.
Trade of the Day: BMY Stock Triggers New Buy Signal
Bristol-Myers Squibb Co appears to be headed to new highs.sa
Buy Bristol-Myers Squibb Co (BMY) Stock Without Fear
The consensus is that Trump will destroy the Biotech industry. I bet this will pass with little change, so go long BMY with room for…
Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here’s why you should buy BMY stock.
2 – 10 of 240 results
